BX vs. VRTX
Compare and contrast key facts about The Blackstone Group Inc. (BX) and Vertex Pharmaceuticals Incorporated (VRTX).
Performance
BX vs. VRTX - Performance Comparison
Loading graphics...
BX vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BX The Blackstone Group Inc. | -24.97% | -7.84% | 35.07% | 82.75% | -40.01% | 107.11% | 19.78% | 96.33% | 0.10% | 27.34% |
VRTX Vertex Pharmaceuticals Incorporated | -1.35% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | 7.94% | 32.13% | 10.58% | 103.42% |
Fundamentals
BX:
$89.28B
VRTX:
$114.54B
BX:
$5.09
VRTX:
$15.35
BX:
22.47
VRTX:
29.14
BX:
0.20
VRTX:
2.42
BX:
6.46
VRTX:
9.60
BX:
10.30
VRTX:
6.14
BX:
$13.83B
VRTX:
$12.00B
BX:
$13.45B
VRTX:
$10.35B
BX:
$7.21B
VRTX:
$4.74B
Returns By Period
In the year-to-date period, BX achieves a -24.97% return, which is significantly lower than VRTX's -1.35% return. Over the past 10 years, BX has outperformed VRTX with an annualized return of 20.32%, while VRTX has yielded a comparatively lower 18.91% annualized return.
BX
- 1D
- -0.57%
- 1M
- -0.87%
- YTD
- -24.97%
- 6M
- -30.59%
- 1Y
- -17.21%
- 3Y*
- 12.62%
- 5Y*
- 12.52%
- 10Y*
- 20.32%
VRTX
- 1D
- 0.16%
- 1M
- -7.98%
- YTD
- -1.35%
- 6M
- 10.65%
- 1Y
- -7.73%
- 3Y*
- 12.39%
- 5Y*
- 15.99%
- 10Y*
- 18.91%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BX vs. VRTX — Risk / Return Rank
BX
VRTX
BX vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Blackstone Group Inc. (BX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BX | VRTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.44 | -0.22 | -0.22 |
Sortino ratioReturn per unit of downside risk | -0.39 | -0.05 | -0.34 |
Omega ratioGain probability vs. loss probability | 0.95 | 0.99 | -0.04 |
Calmar ratioReturn relative to maximum drawdown | -0.34 | -0.28 | -0.07 |
Martin ratioReturn relative to average drawdown | -0.81 | -0.54 | -0.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BX | VRTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.44 | -0.22 | -0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.56 | -0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.57 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.28 | 0.26 | +0.02 |
Correlation
The correlation between BX and VRTX is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
BX vs. VRTX - Dividend Comparison
BX's dividend yield for the trailing twelve months is around 4.15%, while VRTX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BX The Blackstone Group Inc. | 4.15% | 3.04% | 2.00% | 2.54% | 6.66% | 2.76% | 2.95% | 3.43% | 8.12% | 7.25% | 6.14% | 11.76% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BX vs. VRTX - Drawdown Comparison
The maximum BX drawdown since its inception was -87.62%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for BX and VRTX.
Loading graphics...
Drawdown Indicators
| BX | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.62% | -91.77% | +4.15% |
Max Drawdown (1Y)Largest decline over 1 year | -44.76% | -28.06% | -16.70% |
Max Drawdown (5Y)Largest decline over 5 years | -49.29% | -29.07% | -20.22% |
Max Drawdown (10Y)Largest decline over 10 years | -49.29% | -41.60% | -7.69% |
Current DrawdownCurrent decline from peak | -40.10% | -13.45% | -26.65% |
Average DrawdownAverage peak-to-trough decline | -25.60% | -37.81% | +12.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.11% | 14.35% | +4.76% |
Volatility
BX vs. VRTX - Volatility Comparison
The Blackstone Group Inc. (BX) and Vertex Pharmaceuticals Incorporated (VRTX) have volatilities of 11.93% and 11.75%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BX | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.93% | 11.75% | +0.18% |
Volatility (6M)Calculated over the trailing 6-month period | 25.39% | 21.65% | +3.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.68% | 35.79% | +3.89% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.83% | 28.76% | +10.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.55% | 33.24% | +2.31% |
Financials
BX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between The Blackstone Group Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BX vs. VRTX - Profitability Comparison
BX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, The Blackstone Group Inc. reported a gross profit of 4.36B and revenue of 4.36B. Therefore, the gross margin over that period was 100.0%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.72B and revenue of 3.19B. Therefore, the gross margin over that period was 85.4%.
BX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, The Blackstone Group Inc. reported an operating income of 2.36B and revenue of 4.36B, resulting in an operating margin of 54.2%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.26B and revenue of 3.19B, resulting in an operating margin of 39.6%.
BX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, The Blackstone Group Inc. reported a net income of 1.97B and revenue of 4.36B, resulting in a net margin of 45.3%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.19B and revenue of 3.19B, resulting in a net margin of 37.3%.